Flash FinanceUS
Market open S&P 5007,376.86+0.31% Nasdaq24,579.42+1.09% Dow 3051,285.73-0.46% Russell 20002,754.11+0.89% Nasdaq-10026,989.99+1.35% MidCap 4003,602.50+0.56% SmallCap 6001,673.98+0.05% VIX25.64-9.01% 10Y Yield4.86+0.45% Close of Nov 06, 2026
AI brief of an SEC Form 8-K · NEPHROS INC (NEPH)

Nephros Q3 2026 revenue rises 18% to $5.6 million; net income $0.5 million

Positive Impact 3 of 5 earnings Written later

Nephros reported third quarter 2026 net revenue of $5.6 million, up 18% from $4.8 million a year earlier, and net income of $0.5 million, up from $0.3 million. For the first nine months, net revenue rose 20% to $16.9 million and net income reached $1.8 million, but gross margin narrowed, and the company cited a $0.6 million IEEPA tariff refund that helped the nine-month result.

Key points

  • Q3 2026 net revenue $5.6 million vs. $4.8 million in Q3 2025, up 18%; gross margin 58% vs. 61%
  • Q3 2026 net income $0.5 million ($0.05 per diluted share) vs. $0.3 million; Adjusted EBITDA $0.6 million vs. $0.4 million
  • Nine-month net income $1.8 million vs. $1.1 million; cash and cash equivalents about $4.5 million as of September 30, 2026, debt free

The filing

CompanyNEPHROS INC (NEPH)
Form8-K, current report
Filed with the SECNov 5, 2026, 4:06 PM ET
Accession number0001493152-26-050233

Items reported: 2.02 Results of Operations

Read the filing on SEC.gov ↗

Written by AI on Nov 9, 2026, 8:36 AM ET, from this filing only. Written later: this filing was briefed after the fact, when past filings were added to the site, so the brief may be read with hindsight; the filing itself is the record of what was known on November 05, 2026.

Briefs are written by AI from the filing text and can contain mistakes — open the filing before acting on anything. Impact (1-5) and tone are the AI's reading of the filing for shareholders, not a price forecast. Not investment advice.